Evofem Biosciences Stock Price Patterns
| EVFM Stock | USD 0.01 0 10.00% |
Momentum 44
Sell Extended
Oversold | Overbought |
Using Evofem Biosciences hype-based prediction, you can estimate the value of Evofem Biosciences from the perspective of Evofem Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evofem Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Evofem because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Evofem Biosciences after-hype prediction price | USD 0.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Evofem |
Evofem Biosciences After-Hype Price Density Analysis
As far as predicting the price of Evofem Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evofem Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Evofem Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evofem Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Evofem Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evofem Biosciences' historical news coverage. Evofem Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 8.45, respectively. We have considered Evofem Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evofem Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Evofem Biosciences is based on 3 months time horizon.
Evofem Biosciences Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Evofem Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evofem Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evofem Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 8.44 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.01 | 13.64 |
|
Evofem Biosciences Hype Timeline
Evofem Biosciences is currently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Evofem is forecasted to increase in value after the next headline, with the price projected to jump to 0.01 or above. The average volatility of media hype impact on the company the price is insignificant. The price boost on the next news is estimated to be 13.64%, whereas the daily expected return is currently at 0.13%. The volatility of related hype on Evofem Biosciences is about 120571.43%, with the expected price after the next announcement by competition of 0.01. Evofem Biosciences currently holds 125.74 M in liabilities with Debt to Equity (D/E) ratio of 8.72, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evofem Biosciences has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Evofem Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Evofem Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Evofem Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Evofem to invest in growth at high rates of return. When we think about Evofem Biosciences' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Evofem Biosciences Basic Forecasting Models to cross-verify your projections.Evofem Biosciences Related Hype Analysis
Having access to credible news sources related to Evofem Biosciences' direct competition is more important than ever and may enhance your ability to predict Evofem Biosciences' future price movements. Getting to know how Evofem Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evofem Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRZM | Marizyme | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| UNBX | Unity Biotechnology | 0.00 | 0 per month | 11.01 | 0.01 | 22.58 | (17.00) | 87.87 | |
| CAIHF | Chia Tai Enterprises | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIOR | Biora Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BINP | Bionoid Pharma | 0.00 | 0 per month | 13.88 | 0.11 | 34.69 | (36.36) | 176.17 | |
| ISCO | International Stem Cell | 0.00 | 0 per month | 4.89 | 0.01 | 14.29 | (12.50) | 39.08 | |
| BPTH | Bio Path Holdings | (0.07) | 4 per month | 0.00 | (0.03) | 16.67 | (16.67) | 50.79 | |
| BICTF | Biocure Technology | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BMMJ | Body And Mind | 0.00 | 1 per month | 19.48 | 0.05 | 48.57 | (32.31) | 121.50 | |
| CTVEF | Certive Solutions | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Evofem Biosciences Additional Predictive Modules
Most predictive techniques to examine Evofem price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evofem using various technical indicators. When you analyze Evofem charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Evofem Biosciences Predictive Indicators
The successful prediction of Evofem Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evofem Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evofem Biosciences based on analysis of Evofem Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evofem Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evofem Biosciences's related companies.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Evofem Pink Sheet
Evofem Biosciences financial ratios help investors to determine whether Evofem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evofem with respect to the benefits of owning Evofem Biosciences security.